These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27430549)

  • 21. Epidemiological and clinical aspects of urogenital schistosomiasis in women, in Burkina Faso, West Africa.
    Zida A; Briegel J; Kabré I; Sawadogo MP; Sangaré I; Bamba S; Yacouba A; Ouédraogo A; Yonli D; Drabo F; Traoré LK; Ouédraogo-Traoré R; Guiguemdé RT; Wacker J
    Infect Dis Poverty; 2016 Sep; 5(1):81. PubMed ID: 27581074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary study of urinary schistosomiasis in a village in the delta of the Senegal river basin, Senegal.
    Verlé P; Stelma F; Desreumaux P; Dieng A; Diaw O; Kongs A; Niang M; Sow S; Talla I; Sturrock RF
    Trans R Soc Trop Med Hyg; 1994; 88(4):401-5. PubMed ID: 7570817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
    Coulibaly JT; N'gbesso YK; Knopp S; Keiser J; N'Goran EK; Utzinger J
    PLoS Negl Trop Dis; 2012; 6(12):e1917. PubMed ID: 23236526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya.
    Abudho BO; Guyah B; Ondigo BN; Ndombi EM; Ireri E; Carter JM; Riner DK; Kittur N; Karanja DMS; Colley DG
    Infect Dis Poverty; 2020 Jun; 9(1):67. PubMed ID: 32539826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali.
    Deol A; Webster JP; Walker M; Basáñez MG; Hollingsworth TD; Fleming FM; Montresor A; French MD
    Parasit Vectors; 2016 Oct; 9(1):543. PubMed ID: 27729063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Royal Society of Tropical Medicine and Hygiene meeting at Manson House, London, 18 May 1995. The epidemiology of human schistosomiasis in the Senegal river basin.
    Picquet M; Ernould JC; Vercruysse J; Southgate VR; Mbaye A; Sambou B; Niang M; Rollinson D
    Trans R Soc Trop Med Hyg; 1996; 90(4):340-6. PubMed ID: 8882173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children.
    Stothard JR; Sousa-Figueiredo JC; Betson M; Green HK; Seto EY; Garba A; Sacko M; Mutapi F; Vaz Nery S; Amin MA; Mutumba-Nakalembe M; Navaratnam A; Fenwick A; Kabatereine NB; Gabrielli AF; Montresor A
    Parasitology; 2011 Oct; 138(12):1593-606. PubMed ID: 21861945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some aspects of bilharzia in southern Africa.
    Pitchford RJ
    S Afr Med J; 1986 Oct; Suppl():80-2. PubMed ID: 3095935
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rice irrigation and schistosomiasis in savannah and forest areas of Côte d'Ivoire.
    Yapi YG; Briët OJ; Diabate S; Vounatsou P; Akodo E; Tanner M; Teuscher T
    Acta Trop; 2005 Feb; 93(2):201-11. PubMed ID: 15652334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological considerations for development of a schistosome vaccine.
    Mott KE
    Acta Trop Suppl; 1987 Jun; 12():13-20. PubMed ID: 3115073
    [No Abstract]   [Full Text] [Related]  

  • 32. Schistosome infection in Senegal is associated with different spatial extents of risk and ecological drivers for Schistosoma haematobium and S. mansoni.
    Jones IJ; Sokolow SH; Chamberlin AJ; Lund AJ; Jouanard N; Bandagny L; Ndione R; Senghor S; Schacht AM; Riveau G; Hopkins SR; Rohr JR; Remais JV; Lafferty KD; Kuris AM; Wood CL; De Leo G
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009712. PubMed ID: 34570777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of persistent hotspots of Schistosoma mansoni in western Côte d'Ivoire.
    Assaré RK; N'Tamon RN; Bellai LG; Koffi JA; Mathieu TI; Ouattara M; Hürlimann E; Coulibaly JT; Diabaté S; N'Goran EK; Utzinger J
    Parasit Vectors; 2020 Jul; 13(1):337. PubMed ID: 32616074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.
    Shen Y; King CH; Binder S; Zhang F; Whalen CC; Evan Secor W; Montgomery SP; Mwinzi PNM; Olsen A; Magnussen P; Kinung'hi S; Phillips AE; Nalá R; Ferro J; Aurelio HO; Fleming F; Garba A; Hamidou A; Fenwick A; Campbell CH; Colley DG
    BMC Infect Dis; 2017 Sep; 17(1):652. PubMed ID: 28962552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and distribution of schistosomiasis in human, livestock, and snail populations in northern Senegal: a One Health epidemiological study of a multi-host system.
    Léger E; Borlase A; Fall CB; Diouf ND; Diop SD; Yasenev L; Catalano S; Thiam CT; Ndiaye A; Emery A; Morrell A; Rabone M; Ndao M; Faye B; Rollinson D; Rudge JW; Sène M; Webster JP
    Lancet Planet Health; 2020 Aug; 4(8):e330-e342. PubMed ID: 32800151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating survey designs for targeting preventive chemotherapy against Schistosoma haematobium and Schistosoma mansoni across sub-Saharan Africa: a geostatistical analysis and modelling study.
    Fornace KM; Fronterrè C; Fleming FM; Simpson H; Zoure H; Rebollo M; Mwinzi P; Vounatsou P; Pullan RL
    Parasit Vectors; 2020 Nov; 13(1):555. PubMed ID: 33203463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of praziquantel mass drug administration campaign on prevalence and intensity of Schistosoma haemamtobium among school children in Bahi district, Tanzania.
    Chaula SA; Tarimo DS
    Tanzan J Health Res; 2014 Jan; 16(1):1-8. PubMed ID: 26867266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for schistosomiasis with questionnaires.
    Lengeler C; Utzinger J; Tanner M
    Trends Parasitol; 2002 Sep; 18(9):375-7. PubMed ID: 12377245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
    Kura K; Hardwick RJ; Truscott JE; Toor J; Hollingsworth TD; Anderson RM
    Parasit Vectors; 2020 Nov; 13(1):554. PubMed ID: 33203467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.